Cited by 56Attention Deficit Hyperactivity DisorderSleep and related disordersObstructive Sleep Apnea Research

The effect of OROS methylphenidate on the sleep of children with attention-deficit/hyperactivity disorder

Kim, Hyo-Won, Yoon, In-Young, Cho, Soo-Churl, Kim, Boong-Nyun, Chung, Seockhoon, Lee, Hyewon, Kim, Chi-Won, Park, Sung-Kun +1 more·2010·International Clinical Psychopharmacology

Abstract

We evaluated the effect of OROS methylphenidate (MPH) on sleep quality and architecture in children with attention-deficit/hyperactivity disorder (ADHD) using both a parental sleep questionnaire and polysomnography. Twenty-four ADHD children who had no comorbid psychiatric or sleep disorders except for oppositional defiant disorder completed the 6-week, prospective, open-label, flexible-dose trial with OROS MPH (Concerta) monotherapy. After OROS MPH administration, the polysomnography data indicated that the percentage of stage 2 sleep was increased (P=0.024) and the Number of Awakenings was decreased (P=0.047). Relative to baseline, Parasomnias of the Children's Sleep Habits Questionnaire were decreased (P=0.033). Sleep Onset Latency was not changed during the treatment in general, but was increased in six children with subjective sleep difficulties (F(1)=5.832, P=0.025, eta(2)(p)=0.226). Bedtime Resistance and Sleep Onset Delay in Children's Sleep Habits Questionnaire were also increased during the treatment with OROS MPH only in individuals with sleep complaints (F1=5.001, P=0.036, eta(2)(p)=0.185; F(1)=7.237, P=0.013, eta(2)(p)=0.248). These results suggest that OROS MPH in open-label treatment does not seem to impair sleep and may even improve some aspects of sleep.

Integrity signals

Registry

Crossref · 10.1097/yic.0b013e3283364411

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In an open-label polysomnographic study in children with ADHD, OROS-MPH treatment compared with pre-treatment baseline produced only statistically significant decrease in night-time awakenings and increase in percentage of stage 2 sleep.

    “In an open-label polysomnographic study in children with ADHD, the only statistically significant effects of OROS-MPH treatment were a decrease in the number of night-time awakenings and an increase in the percentage of stage 2 sleep, compared with pre-treatment baseline (Kim et al. 2010).”

    From Associations of sleep disturbance with ADHD: implications for treatment (2015) · cites this paper as Kim et al. 2010

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kim, H.-W., Yoon, I.-Y., Cho, S.-C., Kim, B.-N., Chung, S., Lee, H., Kim, C.-W., Park, S.-K., & Yoo, H. J.
Affiliations
  • Dongguk University Ilsan Hospital (KR)
  • Seoul National University (KR)
  • Asan Medical Center (KR)
Corresponding author
Yoo, Hee Jeong
Venue
International Clinical Psychopharmacology
Published
2010-03
Volume
25
Issue
2
Pages
107-115
ISSN
0268-1315 (ISSN-L)
OpenAlex
W2011542738
Cited by
56
References
27
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 1 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 9
FWCI
4.14
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Yale University
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
Keywords
OROS methylphenidate, attention deficit hyperactivity disorder, sleep quality, sleep architecture, stage 2 sleep, nocturnal awakenings, parasomnias, sleep latency, bedtime resistance, sleep onset delay, Children's Sleep Habits Questionnaire, polysomnography, children
MeSH terms
Attention Deficit Disorder with Hyperactivity, Child, Cognition, Data Interpretation, Statistical, Delayed-Action Preparations, Dose-Response Relationship, Drug, Electrocardiography, Female, Humans, Male, Methylphenidate, Psychiatric Status Rating Scales, Surveys and Questionnaires, Linear Models, Treatment Outcome, Polysomnography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review